Redirecting to https://www.news.sanofi.us/2026-07-10-Sanofis-subcutaneous-Sarclisa-Escena-approved-in-the-US-as-first-anticancer-treatment-administered-via-on-body-injector...

Click here if your browser doesn't automatically take you to this page.